The Company publishes all Annual Reports. Click on the link to download the selected Annual Report.
Imugene commences cGMP manufacture of PD-1 cancer vaccine
Imugene appoints gastrointestinal cancer expert to Scientific Advisory Board
Imugene Completes Phase 1b Cancer Vaccine Trial Recruitment
© Imugene 2018. All rights reserved. ABN 99 009 179 551